In healthcare, providers and lawmakers are faced with the task of making the best possible decisions for patients and the industry as a whole. From choosing the best treatments, to determining the most...
Decision-makers should take several criteria into account when assessing the usefulness of COVID-19 data points, according to a new guide by the National Academies of Sciences, Engineering and...
An analysis of county-level data revealed progress in reducing premature cardiac deaths in began to decline in 2011, with significant disparities among counties, according to research published in the...
As the healthcare industry continues to seek solutions to track and control the spread of COVID-19, patient matching and data standardization have surfaced as effective responses to the pandemic.
For...
When evaluating COVID-19 data to inform policies, decision-makers should consider five criteria to better understand the spread of the virus in their communities: representativeness, potential...
COVID-19 death rates in the US are correlated with patients’ age, race, socioeconomic status, and other social determinants of health data, according to a study led by researchers at the MIT...
A big data model projected that without any changes in alcohol consumption or interventions to address high-risk drinking, deaths from alcohol-related liver disease will rise significantly in the US,...
A new analysis of COVID-19 data in 58 cities showed that for each day’s delay in social distancing, a coronavirus outbreak lasts days longer.
For more coronavirus updates, visit...
Researchers at Vanderbilt’s Data Science Institute are developing a model that will use big data to address the impact of COVID-19 on policies, procedures, and resources now and in the...
An international team of researchers has developed a new method to leverage multiple data-driven models for COVID-19 outbreak management.
For more coronavirus updates, visit our resource page,...
In the context of COVID-19, state-level decision-makers should conduct risk assessments to better understand how to move from strict social distancing measures to a staged reopening phase, according to...
The Department of Defense (DoD) has adopted a series of ethical principles for the use of artificial intelligence following recommendations made by the Defense Innovation Board last October.
The...
The FDA approved or cleared 12 personalized medicines and seven diagnostics in 2019, helping providers address the root causes of disease and further integrating precision medicine with clinical...
The Institute for Gene Therapies (IGT), a new advocacy foundation focused on policy issues surrounding gene therapies, recently launched with the goal of modernizing US regulatory and reimbursement...
The Pharmacy Quality Alliance (PQA) is partnering with the Chesapeake Regional Information System for our Patients (CRISP) to map four PQA opioid measures so the organizations can utilize...
Machine learning algorithms have the potential to accelerate and refine the drug development process, but the industry should expand data access and create consistent data standards to ensure drug...
The American Medical Informatics Association (AMIA) is recommending that NIH dramatically revise its data sharing and management proposal to maximize the value of scientific data.
In October 2018, NIH...
The American Medical Informatics Association (AMIA) has expressed its support for the FDA’s updated guidance for regulating clinical decision support (CDS) software, but experts are also calling...
